Between 20,000 and 40,000 people in the United States are diagnosed with lung cancer each year despite never having smoked. That accounts for 10% to 20% of all lung cancer cases. If lung cancer in never-smokers were tracked as its own category, it would rank among the top ten causes of cancer death in the country. The causes range from invisible gases in your home to genetic mutations you’re born with.
Radon Gas in Your Home
Radon is the leading cause of lung cancer in non-smokers. It’s a naturally occurring radioactive gas that seeps up from soil and rock into buildings through cracks in foundations, gaps around pipes, and other openings. You can’t see it, smell it, or taste it. As radon breaks down, it releases tiny radioactive particles that, when inhaled, damage the cells lining your lungs. Over years of exposure, that damage can trigger cancer.
The EPA recommends taking action if your home’s radon level reaches 4 picocuries per liter (pCi/L) or higher. But there is no known safe level of radon exposure, so the agency also suggests considering mitigation for levels between 2 and 4 pCi/L. Testing is simple and inexpensive: hardware stores sell short-term test kits, and professional testers can provide more precise readings. If levels are high, a radon mitigation system (essentially a ventilation pipe and fan installed beneath the foundation) typically brings concentrations down to safe ranges.
Secondhand Smoke
Living or working around people who smoke raises your lung cancer risk by 20% to 30%, according to the CDC. The smoke that drifts from a burning cigarette and the smoke exhaled by a smoker contain the same carcinogens that cause cancer in smokers themselves. Long-term exposure matters most: years of sharing a home with a smoker or working in a smoke-filled environment accumulate the greatest risk.
Air Pollution
The World Health Organization’s cancer research agency classifies outdoor air pollution as a Group 1 carcinogen, the same category as tobacco smoke and asbestos. Fine particulate matter (the tiny particles known as PM2.5, small enough to penetrate deep into your lungs) received its own separate Group 1 classification.
These particles cause damage at the molecular level. They silence tumor-suppressing genes by altering how DNA is read, switch on cancer-promoting pathways, and trigger chronic inflammation in lung tissue. Research on human lung cells has shown that even concentrations considered “safe” by air quality standards can inactivate p53, one of the body’s most important tumor-suppressing genes, after sustained exposure. People living near highways, industrial zones, or in cities with persistent smog face higher cumulative exposure over a lifetime.
Workplace Carcinogens
Certain jobs expose workers to substances that are confirmed causes of lung cancer. The most well-known is asbestos, a fiber once widely used in insulation, roofing, and fireproofing. When inhaled over time, asbestos fibers lodge in lung tissue and cause cellular damage that can eventually become cancerous. The risk is highest for workers who handled asbestos directly, but even secondary exposure (such as washing a family member’s contaminated work clothes) has been linked to disease.
Other confirmed occupational lung carcinogens include:
- Metals: arsenic, chromium, cadmium, nickel, and beryllium compounds
- Dusts: crystalline silica dust (common in mining, construction, and stone cutting)
- Chemical exposures: diesel exhaust, coal tar, and soot
- Industries: aluminum production, coke production, iron and steel founding, painting, and rubber manufacturing
Modern workplace safety regulations have reduced these exposures significantly, but workers in older facilities or in countries with less enforcement remain at elevated risk. The lag between exposure and diagnosis is often decades, so cancers appearing today may trace back to workplace conditions from the 1980s or 1990s.
Genetic Mutations That Drive Non-Smoker Lung Cancer
Lung cancer in people who have never smoked tends to look different at the molecular level than lung cancer caused by smoking. Non-smokers are far more likely to have tumors driven by specific, identifiable genetic mutations, particularly in a gene called EGFR (epidermal growth factor receptor). In one large study, 33.3% of non-smokers with lung adenocarcinoma carried an EGFR mutation, compared to just 9.5% of smokers. Another mutation, called ALK rearrangement, also appears more frequently in never-smokers.
This distinction matters for treatment. Tumors driven by EGFR or ALK mutations often respond well to targeted therapies, pills that block the specific protein fueling the cancer’s growth. These treatments tend to have fewer side effects than traditional chemotherapy and can be remarkably effective. This is one reason oncologists now routinely test non-smokers’ tumors for these mutations.
The pattern is especially pronounced in certain groups. EGFR mutations are more common in women, people of Asian descent, and people who have never smoked. This helps explain why lung cancer in non-smokers disproportionately affects these populations.
Family History and Inherited Risk
Having a close relative with lung cancer increases your own risk, even if neither of you ever smoked. Researchers have identified multiple genetic variants associated with lung cancer susceptibility, though the exact mechanisms are still being mapped. Recent work from the National Cancer Institute used advanced genomic techniques to pinpoint how certain inherited variants affect gene regulation in specific lung cell types, essentially changing how actively certain regions of your DNA operate in the cells most vulnerable to cancer.
Inherited risk doesn’t mean lung cancer is inevitable. It means your cells may be slightly less resilient to damage from other exposures on this list, or slightly more prone to the kind of unchecked cell growth that leads to tumors.
Previous Lung Disease
Chronic lung conditions create an environment of ongoing inflammation and tissue repair that raises cancer risk. Idiopathic pulmonary fibrosis (a condition where lung tissue becomes scarred and stiff) carries a lung cancer incidence of 22% to 31%. Chronic obstructive pulmonary disease, or COPD, carries a rate of roughly 7% to 11%. When both conditions overlap, the risk climbs even higher, reaching 36% to 47% in some studies.
The connection is partly biological: inflamed, damaged tissue undergoes constant cell division to repair itself, and each round of division is an opportunity for a cancerous mutation to take hold. It’s also partly because these conditions share some of the same environmental triggers, like air pollution and occupational dust exposure, that independently raise cancer risk.
Why Non-Smokers Often Get Diagnosed Late
One of the biggest challenges for non-smokers with lung cancer is timing. Because lung cancer screening guidelines are designed around smoking history, people who have never smoked rarely qualify for routine low-dose CT scans. Doctors may also be slower to suspect lung cancer when a non-smoker presents with a persistent cough or unexplained weight loss. The result is that non-smokers are frequently diagnosed at a later stage, when treatment options are more limited.
If you have significant radon exposure, a strong family history of lung cancer, or years of occupational exposure to known carcinogens, it’s worth discussing your individual risk with a doctor, even if you’ve never touched a cigarette. A persistent cough lasting more than a few weeks, unexplained shortness of breath, chest pain, or coughing up blood all warrant prompt evaluation regardless of smoking status.